Document Classification

Section Type: METHODS

Text: Patients with unresected stages IIIA and IIIB NSCLC, with Karnofsky performance status > or = 70 % and weight loss < or = 10 %, received two cycles of induction paclitaxel (200 mg/m2) / carboplatin (area under the plasma concentration time curve [AUC] = 6) followed by TRT 63. 0 Gy (arm 1, sequential) or two cycles of induction paclitaxel (200 mg/m2) / carboplatin (AUC = 6) followed by weekly paclitaxel (45 mg/m2) / carboplatin (AUC = 2) with concurrent TRT 63. 0 Gy (arm 2, induction/concurrent), or weekly paclitaxel (45 mg/m2) / carboplatin (AUC = 2) / TRT (63. 0 Gy) followed by two cycles of paclitaxel (200 mg/m2) / carboplatin (AUC = 6 ; arm 3, concurrent/consolidation).